Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
about
Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter regionHigh-risk myelodysplastic syndromes and hypermethylation of the p15Ink4B gene.Differential methylation of genes associated with cell adhesion in preeclamptic placentas.Roles of cell division and gene transcription in the methylation of CpG islands.Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia.Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas.NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia.Malignancy: Tumor Suppressor Gene Aberrations in Acute Myelogenous Leukemia.Novel therapies for patients with chronic myeloid leukemia.Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients.Epigenetic therapy with decitabine for myelodysplasia and leukemia.Aberrant silencing of the CpG island-containing human O6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning.Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases.DNA methylation: its role in cancer development and therapy.DNA methylation in cancer development, diagnosis and therapy--multiple opportunities for genotoxic agents to act as methylome disruptors or remediators.Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.Methylation-associated transcriptional silencing of the major histocompatibility complex-linked hsp70 genes in mouse cell lines.DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia.Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele.Methylation of CpG dinucleotides in the open reading frame of a testicular germ cell-specific intronless gene, Tact1/Actl7b, represses its expression in somatic cells.Are ABL and BCR imprinted?p53 mutations, methylation and genomic instability in the progression of chronic myeloid leukaemia.DNA methylator and mismatch repair phenotypes are not mutually exclusive in colorectal cancer cell lines.Heritable gene repression through the action of a directed DNA methyltransferase at a chromosomal locus.Methylation status of CEBPA gene promoter in chronic myeloid leukemia.Phase I/II study of low-dose azacytidine in patients with chronic myeloid leukemia who have minimal residual disease while receiving therapy with tyrosine kinase inhibitors.
P2860
Q24810666-5D2CF776-51EB-4ED9-B1B7-3030FF0AB564Q33536277-6937E164-6EA8-40BD-A515-FFCF57E2BF93Q33806626-E8EF375E-FD13-4263-A0D6-083BE3CB5439Q33959680-6D27A6F4-FE9C-4C02-9E20-07B4EDE8EA40Q33961765-64A03690-7146-4908-A465-CBB08DBAB45AQ34053843-39790988-4474-43E9-9C52-394D0A8B17A9Q34176567-0F68A6E1-1C15-462D-96A9-3CEF4F026931Q34278271-B7D856E7-BD30-4C6C-871A-766C6EE6C047Q35728742-D3F69ED6-C009-4C8F-B89A-2A5F08263A28Q36142412-B895A870-F1E5-45AF-A882-4AB2369E44EDQ36429559-1290647E-09C3-4AF2-B074-63E1BEF576CEQ36573030-6481DF33-AD14-404D-9496-DE1C592A639EQ36822880-FF5BDA14-8B85-46A1-BF7E-F68ECAD4CFD8Q36851400-8256E760-4789-4C25-BF42-C0EE4AD1AA6EQ36986433-399B26F2-5567-4FB2-BDBD-16B2DA8C7C5FQ37873228-ED26056E-26D8-44E6-8953-95A4FC02BAE9Q38193659-CF0C3F34-8935-4FDE-966A-6CBDEA32C463Q38289376-491DE057-502C-44CA-BC20-221B22DAEEB4Q38941081-C4FEB660-252B-437D-B08D-E5B0E8C4C1C2Q39520549-FC698A53-62DB-44DD-A573-454D0F07B301Q39808706-434A8524-E581-4FA4-9600-291D142510A3Q41167757-8723F3BB-2810-4EB7-8323-39BEA92B2EB8Q41607022-6028C9AC-3CD2-44D1-A374-D4DED3CB5A43Q41723122-369128EF-F881-414D-A3DD-D0D18266C1A2Q42816880-EF650168-576E-4A36-A2A3-D476182C834CQ54266084-AA7DF460-F08D-4C32-8A81-687CFBFF4CA3Q54839818-253DD63C-2395-4D39-AB10-B6C3797E8F60
P2860
Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Progressive de novo DNA methyl ...... chronic myelogenous leukemia.
@ast
Progressive de novo DNA methyl ...... chronic myelogenous leukemia.
@en
type
label
Progressive de novo DNA methyl ...... chronic myelogenous leukemia.
@ast
Progressive de novo DNA methyl ...... chronic myelogenous leukemia.
@en
prefLabel
Progressive de novo DNA methyl ...... chronic myelogenous leukemia.
@ast
Progressive de novo DNA methyl ...... chronic myelogenous leukemia.
@en
P2093
P2860
P356
P1476
Progressive de novo DNA methyl ...... chronic myelogenous leukemia.
@en
P2093
Ben-Neriah Y
Ben-Yehuda D
P2860
P304
10722-10726
P356
10.1073/PNAS.91.22.10722
P407
P577
1994-10-01T00:00:00Z